Kamada (KMDA) Reports Q2 Loss Per Share of 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Kamada Reports Second Quarter 2015 Financial Results
July 30, 2015 7:00 AM EDTConference call begins today at 8:30 a.m. Eastern time
NESS ZIONA, Israel--(BUSINESS WIRE)-- Kamada Ltd. (NASDAQ: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and six months ended June 30, 2015.
Financial highlights of the 2015 second quarter included:
Total revenues of $19.2 million compared with $15.8 million for the second quarter of 2014; Gross profit of $3.6 million compared with a gross loss of $0.10 million in the year-ago second quarter; and... More